Retatrutide 32mg Self-Mix | Triple-Action Weight Loss Peptide
GLP-1 + GIP + Glucagon Receptor Agonist | Advanced Metabolic Therapy
🎯 Benefits | Why Choose Noventra Pharma Retatrutide
💊 Triple-Action Weight Loss
Targets GLP-1, GIP and glucagon receptors simultaneously to support powerful fat loss and appetite suppression.
🔥 Advanced Metabolic Boost
Supports increased energy expenditure and improved fat metabolism for effective body composition changes.
🚚 Fast South Africa Delivery
Discreet and fast nationwide shipping across South Africa.
Clinical Indications
- ✓ Advanced Weight Management: Designed to support significant fat reduction and appetite control.
- ✓ Metabolic Health Support: Improves insulin sensitivity and glucose regulation.
- ✓ Visceral Fat Reduction: Promotes fat oxidation and reduction of abdominal fat.
- ✓ Cardiometabolic Support: May assist in improving cholesterol and metabolic markers.
How Retatrutide Works | Mechanism of Action
GLP-1 Receptor Activation
Helps suppress appetite, slow gastric emptying, and improve insulin secretion for better blood sugar control.
GIP Receptor Support
Enhances insulin response and supports fat metabolism for improved metabolic efficiency.
Glucagon Receptor Activation
Promotes thermogenesis and increased energy expenditure, helping the body burn more calories.
Usage Protocol
Week 1
2.5mg weekly
Week 2-3
5mg weekly
Maintenance
7.5mg weekly
Technical Specifications
Concentration:
32mg peptide vial
Included:
2ml bacteriostatic water
Storage:
Store refrigerated at 2-8°C
Manufacturer:
Noventra Pharma
⚕️ Professional Healthcare Notice
Retatrutide is a triple-agonist metabolic therapy targeting GLP-1, GIP and glucagon receptors involved in appetite and energy metabolism. It has demonstrated significant weight reduction and metabolic improvements in clinical trials, but remains under clinical investigation. Consult a healthcare professional before use.
